{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:30:31Z","timestamp":1782603031218,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jhep.2021.08.008","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T06:22:36Z","timestamp":1629958956000},"page":"1434-1439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases"],"prefix":"10.1016","volume":"75","author":[{"given":"Paul J.","family":"Thuluvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Robarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahak","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jhep.2021.08.008_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2021.08.008_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12072-020-10078-2","article-title":"Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis","volume":"14","author":"Kovalic","year":"2020","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.jhep.2021.08.008_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.31472","article-title":"Elevated liver biochemistries\u00a0in hospitalized Chinese patients with severe COVID-19: systematic review and meta-analysis","volume":"73","author":"Kovalic","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2021.08.008_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2020.11.045","article-title":"Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA\/ELTR Multi-center European Study","volume":"160","author":"Belli","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jhep.2021.08.008_bib5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S2468-1253(20)30271-5","article-title":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study","volume":"5","author":"Webb","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2021.08.008_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.08.008_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.01.047","article-title":"An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology","author":"Gresham","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jhep.2021.08.008_bib8","first-page":"e95","article-title":"Korean college of rheumatology task force for COVID-19 vaccine guidance for patients with autoimmune inflammatory rheumatic diseases","volume":"36","author":"Park","year":"2021","journal-title":"J\u00a0KorMed Sci"},{"issue":"1","key":"10.1016\/j.jhep.2021.08.008_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13223-021-00529-2","article-title":"COVID-19 vaccine testing & administration guidance for allergists\/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)","volume":"17","author":"Vander Leek","year":"2021","journal-title":"Allerg Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.jhep.2021.08.008_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41575-021-00420-w","article-title":"SARS-CoV-2 vaccination in IBD: more pros than cons","volume":"18","author":"D'Amico","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2021.08.008_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10067-020-05547-w","article-title":"Covid-19 vaccination in immunocompromised","volume":"40","author":"Sonani","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jhep.2021.08.008_bib12","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.2021.4385","article-title":"Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2021.08.008_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.03149-20","article-title":"Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation","author":"Higgins","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.jhep.2021.08.008_bib15","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1172\/JCI142004","article-title":"Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population","volume":"130","author":"Klein","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2021.08.008_bib16","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10620-020-06437-6","article-title":"Two-Dose Hepatitis B Vaccine (Heplisav-B) results in better seroconversion than three-dose vaccine (Engerix-B) in chronic liver disease","volume":"66","author":"Amjad","year":"2021","journal-title":"Dig Dis Sci"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782102002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782102002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:15:11Z","timestamp":1748279711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782102002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S016882782102002X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.08.008","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}